Inventor
HITOSHI BAN
Inventor
JP
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds21%
C07KPeptides9%
Y02ATechnologies for adaptation to climate change4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
A61LMethods or apparatus for sterilising materials or objects in general1%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
12,559,487Crosslinked optically active secondary amine derivative202612,440,560Substituted pyrimidines as vaccine adjuvants202512,427,192Water soluble adjuvant and composition containing same202512,410,1545-heteroaryl-1H-pyrazol-3-amine derivative202512,398,149Dihydrochromene derivatives202512,383,608WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides202512,263,167Optically active azabicyclo ring derivative202512,178,879Hemiasterlin derivative and antibody-drug conjugate thereof202412,018,093Hemiasterlin derivatives and antibody-drug conjugates including same202411,911,381Optically active azabicyclo ring derivative202411,911,466Substituted pyrimidines as vaccine adjuvants202411,795,195Antibody-drug conjugates including hemiasterlin derivative202311,759,509WT1 antigen peptide conjugate vaccine202311,661,3971,4-disubstituted imidazole derivative202311,639,357Dihydrochromene derivatives202311,564,9205-heteroaryl-1H-pyrazol-3-amine derivative202311,434,472Agent for removing undifferentiated iPS cells202211,414,394Process for producing a hydrate of a hydrochloride salt of 2,2'-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid202211,369,605Optically active azabicyclo ring derivative202211,325,921Optically active crosslinked cyclic secondary amine derivative202211,279,694Alvocidib prodrugs and their use as protein kinase inhibitors202211,266,738Substituted pyrimidines as vaccine adjuvants2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to SUMITOMO PHARMA CO LTD (18)· patent assignee history
2022Patents assigned to SUMITOMO DAINIPPON PHARMA CO LTD (3)· patent assignee history
2022Patents assigned to SUMITOMO DAINIPPON PHARMA ONCOLOGY INC (1)· patent assignee history
2022Patents assigned to SUMITOMO PHARMA ONCOLOGY INC (1)· patent assignee history
2022–2026Based in JP· patent location history
2023–2025Patents assigned to INT INST CANCER IMMUNOLOGY INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SUMITOMO PHARMA CO LTD | 18 | 2022–2026 |
| SUMITOMO DAINIPPON PHARMA CO LTD | 3 | 2022 |
| INT INST CANCER IMMUNOLOGY INC | 2 | 2023–2025 |
| SUMITOMO DAINIPPON PHARMA ONCOLOGY INC | 1 | 2022 |
| SUMITOMO PHARMA ONCOLOGY INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 22 | 2022–2026 |